Celon Pharma (WAR:CLN) ROE % Adjusted to Book Value : 16.62% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Celon Pharma ROE % Adjusted to Book Value?

Celon Pharma's ROE % for the quarter that ended in Sep. 2024 was 46.88%. Celon Pharma's PB Ratio for the quarter that ended in Sep. 2024 was 2.82. Celon Pharma's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 16.62%.

Celon Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Celon Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celon Pharma ROE % Adjusted to Book Value Chart

Celon Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

0.67

-0.04

-0.92

-5.10

-3.44

Celon Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-3.46	-7.47	-7.97	-4.16	16.62

Competitive Comparison of Celon Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Celon Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celon Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celon Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Celon Pharma's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Celon Pharma ROE % Adjusted to Book Value Calculation

Celon Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-6.08%	/	1.77
	=	-3.44%

Celon Pharma's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	46.88%	/	2.82
	=	16.62%

Celon Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Celon Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Celon Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celon Pharma SA (WAR:CLN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

8RP:Germany

Address

Ogrodowa 2A, Kielpin, Lomianki, POL, 05-092

Website

http://www.celonpharma.com

Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.

Celon Pharma Headlines

No Headlines